Non-steroidal anti-inflammatory drugs in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit.
- 21 January 1989
- Vol. 298 (6667) , 177-178
- https://doi.org/10.1136/bmj.298.6667.177
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.BMJ, 1988
- The protective effects of sulphasalazine against ethanol-induced gastric damage in ratsBritish Journal of Pharmacology, 1987
- Management of NSAID induced gastrointestinal disturbance.Annals of the Rheumatic Diseases, 1987
- Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease.Gut, 1987
- Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.BMJ, 1987
- NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCERThe Lancet, 1986
- ASYMPTOMATIC GASTRIC ULCER: A FOLLOW-UP STUDY IN PATIENTS WITH PREVIOUS GASTRIC ULCER DISEASEThe Lancet, 1985
- Bleeding from peptic ulcers and use of non-steroidal anti-inflammatory drugs in the Romford area.BMJ, 1985
- Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation, 1985
- Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirinDigestive Diseases and Sciences, 1982